BTC $55865.7639
ETH $3222.4858
BNB $400.6682
SOL $110.6842
XRP $0.5548
ADA $0.6230
AVAX $39.2767
DOGE $0.0896
TRX $0.1404
wstETH $3751.1765
LINK $19.0474
DOT $8.0594
WETH $3236.9354
MATIC $1.0625
UNI $10.5983
WBTC $55965.3668
IMX $3.3901
ICP $13.0143
BCH $300.6764
LTC $74.8911
CAKE $3.2355
FIL $8.1517
ETC $28.1561
RNDR $7.4096
KAS $0.1718
DAI $0.9979
HBAR $0.1117
ATOM $11.3293
VET $0.0491
INJ $36.5642
TON $2.1072
OKB $51.3395
LDO $3.5443
FDUSD $1.0015
STX $3.0723
ARB $1.9162
NEAR $4.0168
XMR $131.7677
TIA $17.0755
XLM $0.1186
GRT $0.2823
ENS $22.2643
THETA $2.1117
MKR $2155.4331
WEMIX $2.1023
APEX $2.4575
BEAM $0.0357
BTC $55865.7639
ETH $3222.4858
BNB $400.6682
SOL $110.6842
XRP $0.5548
ADA $0.6230
AVAX $39.2767
DOGE $0.0896
TRX $0.1404
wstETH $3751.1765
LINK $19.0474
DOT $8.0594
WETH $3236.9354
MATIC $1.0625
UNI $10.5983
WBTC $55965.3668
IMX $3.3901
ICP $13.0143
BCH $300.6764
LTC $74.8911
CAKE $3.2355
FIL $8.1517
ETC $28.1561
RNDR $7.4096
KAS $0.1718
DAI $0.9979
HBAR $0.1117
ATOM $11.3293
VET $0.0491
INJ $36.5642
TON $2.1072
OKB $51.3395
LDO $3.5443
FDUSD $1.0015
STX $3.0723
ARB $1.9162
NEAR $4.0168
XMR $131.7677
TIA $17.0755
XLM $0.1186
GRT $0.2823
ENS $22.2643
THETA $2.1117
MKR $2155.4331
WEMIX $2.1023
APEX $2.4575
BEAM $0.0357
  • Catalog
  • Blog
  • Tor Relay
  • Jabber
  • One-Time notes
  • Temp Email
  • What is TOR?
  • We are in tor
  • A study aimed at studying the effectiveness of marijuana in the treatment of opioid dependence began in South Africa


    South Africa's Therapeutic Cannabis Research Institute (CRI) has announced that the government has approved a clinical trial to evaluate the effectiveness of cannabis as a treatment for opiate addiction. This project, which the organization will conduct with the support of sponsors from Releaf Cannabis E-Clinics, will be the first clinical trial of its kind in the history of the republic.

    According to the representatives of the public organization themselves, the project will last at least one year, during which scientists will observe how the use of cannabinoids affects the psychological and physiological state of the subjects, as well as how these substances affect their perceived craving for opiate drugs. Medical professionals want to know if the use of cannabinoids affects the physical sensation of pain and discomfort in the body experienced by many people trying to get rid of opiate addiction.

    The head of the project will be a well-known hemp medicine specialist in South Africa, Dr. Shiksha Gallow. Actually, she confirmed to the media that the research project had already been approved by the regulators of the republic, and that the team was already ready for its launch.

    “Currently, the South African authorities do not support the use of cannabis in the treatment of opiate addiction, in particular the consequences of the drug withdrawal syndrome that all people who quit opiates face. Preliminary data, in the form of local and foreign private studies, allow us to believe that cannabis can be used in this capacity, however, we do not have strong enough evidence of such an effect. Actually, the new project aims to find evidence of the possibility of the effective use of hemp and the active substances of the plant in this field of medicine,” the doctor tells reporters.

    Also, the doctor does not exclude that the study will reveal new data on the nature of the work of pain receptors in the human body, as well as on their contact with various active compounds that affect their activity. As Dr. Gallow suggests, it is possible that some of these mechanisms can be effectively exploited with the help of exogenous and endogenous cannabinoids, modulating their activation and strength of work. Potentially, such a technique could allow humanity to completely replace "dangerous" painkillers, in the form of the same opiates, with safe and non-addictive cannabinoids.

    "In fact, we can find a solution to a whole range of problems associated with opiate drugs, ranging from the risks of their use to human health, to side effects, such as the development of dependence in patients and crimes associated with this factor," says the doctor.

    Preliminary trials have already started in June of this year, led by another CRI partner, Labat Africa and its subsidiary Biodata, which tested the effectiveness of cannabis as a pain reliever with a group of 1,000 volunteers. In the trial, which demonstrated the high safety and efficacy of cannabinoids, the company used locally produced new therapeutic varieties called Tallyman and Exodus. The company that provided them, Sweetwaters Aquaponics, has already launched these plants into the national medical market, along with another new creation, 9 Pound Hammer, which contains a significant admixture of CBG, balanced with THC.

    Author DeepWeb
    Attackers once again decided to cash in on Black Friday and Apple fans
    Experts have discovered the largest underground market in the dark web

    Comments 0

    Add comment